← FDA DRUG APPROVALS

FDA ANDA · ANDA209832

SODIUM NITROPRUSSIDE

Sponsor: AMPHASTAR PHARMS INC

APPLICATION
ANDA209832
TYPE
ANDA
ORIGINAL APPROVAL
2017-12-18
LATEST ACTION
2017-12-18
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

SODIUM NITROPRUSSIDEDiscontinued
SODIUM NITROPRUSSIDE 25MG/ML · INJECTABLE · INJECTION

Approval history

2017-12-18UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →